Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease

This publication has 12 references indexed in Scilit:

• Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion
  Acta Neuropathologica, 2012
• Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington’s, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease
  Acta Neuropathologica, 2012
• p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS
  Acta Neuropathologica, 2011
• Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72
  Acta Neuropathologica, 2011
• Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
  Neuron, 2011
• FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease
  Neuropathology and Applied Neurobiology, 2011
• Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
  Nature, 2011
• Mutations of optineurin in amyotrophic lateral sclerosis
  Nature, 2010
• Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
  Science, 2009
• Identification of ubiquitin‐interacting proteins in purified polyglutamine aggregates
  FEBS Letters, 2004